Skip to main content
MJH Life Sciences
  • Login
  • Register
  • Login
  • Register
Home
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences
MJH Life Sciences

SUBSCRIBE: Print / eNewsletter

Christina Bennett, MS

Is Prophylactic Irradiation After Chest Wall Procedure Beneficial in Mesothelioma?

May 30, 2019
  • Christina Bennett, MS

Researchers tested whether prophylactic irradiation after a chest wall procedure would benefit patients with malignant pleural mesothelioma.

  • READ >>

Can Crowdsourcing Lead to Artificial Intelligence Tools for Radiation Oncologists?

May 22, 2019
  • Christina Bennett, MS

A worldwide crowd innovation contest incentivized international programmers to create automated AI algorithms for an area of radiation oncology.

  • READ >>

First-Line Therapy for Metastatic RCC Remains Controversial Amid New Approvals

May 16, 2019
  • Christina Bennett, MS

The bar for the standard of care among patients with advanced renal cell carcinoma is set high as various promising combination therapies recently received FDA approval.

  • READ >>

Long-Term Data Support Stereotactic Body Radiotherapy for Centrally Located NSCLC

May 9, 2019
  • Christina Bennett, MS

The findings further validate the initial 2015 findings that a five-fraction SBRT schedule is appropriate for patients with centrally located NSCLC.

  • READ >>

Does Hypothyroidism Impact Risk of Breast Cancer Recurrence or Death?

May 8, 2019
  • Christina Bennett, MS

Researchers evaluated whether breast cancer patients with hypothyroidism at diagnosis or who develop it later have an increased risk of recurrence or death.

  • READ >>

Exercise Proves Beneficial for Breast Cancer Survivors, Yet Again

May 8, 2019
  • Christina Bennett, MS

The results of a new study add to the list of benefits seen with exercise among breast cancer survivors: reducing the risk of cardiovascular disease.

  • READ >>

Pembrolizumab Provides Hope for PD-L1–Positive Cervical Cancer Patients

May 7, 2019
  • Christina Bennett, MS

The phase II KEYNOTE-158 basket trial evaluated single-agent pembrolizumab in patients with previously treated advanced cervical cancer.

  • READ >>

Incidence of Adverse Events for PD-1/PD-L1 Inhibitors Underscores Toxicity Risk

May 7, 2019
  • Christina Bennett, MS

A review and meta-analysis in JAMA Oncology evaluated the incidence of treatment-related adverse events in patients receiving PD-1 or PD-L1 therapy.

  • READ >>

Early Results for Next-Generation TRK Inhibitor LOXO-195 Look “Very Promising”

April 23, 2019
  • Christina Bennett, MS

The investigators tested the agent in patients who had solid tumors with NTRK gene fusions that had developed resistance to other TRK inhibitors.

  • READ >>

Is It Too Soon to Augment Lung Cancer Screening Guidelines for High-Risk Patients?

April 12, 2019
  • Christina Bennett, MS

A study looked at whether a lung cancer risk prediction model could identify patients at high risk for lung cancer who could receive less frequent low-dose CT screening.

  • READ >>

Pages

  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • next ›
  • last »

Resource Topics rightRail

  • Resource Topics
  • Partner Content
  • Breast Cancer
  • Acute Myeloid Leukemia
  • HER2-Positive Breast Cancer
  • Videos Breast Cancer
  • Follicular Lymphoma
Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sézary Syndrome
3 Keys to Success in the Oncology Care Model

Current Issue

ONCOLOGY Vol 33 No 11
Nov 21, 2019 Vol 33 No 11
Subscribe
Connect with Us
  • Column 1
    • Home
    • About Us
    • Contact Us
  • Column 2
    • Editorial Info
    • Editorial Board
  • Column 3
    • Advertising Info
    • Reprints
    • Advertising Terms
  • Column 4
    • Terms of Use
    • Privacy Policy
Modern Medicine Network
© UBM 2019, All rights reserved.
Reproduction in whole or in part is prohibited.

We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".